Results 161 to 170 of about 134,252 (360)
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz +2 more
wiley +1 more source
Using Transdermal Buprenorphine to Treat Chronic Pruritus in a Young Adult with Lymphoma and Anxiety [PDF]
Miranda Ravicz +2 more
openalex +1 more source
Complement activation is implicated in Huntington's disease; ANX005 is a potent inhibitor of component C1q. ANX005 exhibited a generally manageable safety profile with rapid reduction in C1q in the cerebrospinal fluid. Functional ability on composite Unified Huntington's Disease Rating Scale and total functional capacity was maintained, with potential ...
Rajeev Kumar +15 more
wiley +1 more source
To study efficacy of Nimba on Yonikanda WSR to pruritus vagina [PDF]
Shamika S Joshi, Jayashree S Deshmukh
openalex +1 more source
Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis [PDF]
Shawn G. Kwatra +8 more
openalex +1 more source
Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency
ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak +2 more
wiley +1 more source
Skin disease in captive bats: results of an online survey of zoos and rehabilitators in Europe, North America and Australasia [PDF]
Bello-Gutiérrez +15 more
core +2 more sources
LB1241 Immune dysregulation and CCL3-induced neuronal sensitization underlie chronic pruritus of unknown origin [PDF]
Li Zhang, Limin Lun, Fei Wang
openalex +1 more source

